146 related articles for article (PubMed ID: 28833354)
41. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
Perry C; Herishanu Y; Metzer U; Bairey O; Ruchlemer R; Trejo L; Naparstek E; Sapir EE; Polliack A
Eur J Haematol; 2007 Sep; 79(3):205-9. PubMed ID: 17662066
[TBL] [Abstract][Full Text] [Related]
42. Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma.
Patil A; Manzano M; Gottwein E
Blood Adv; 2019 Jul; 3(14):2105-2117. PubMed ID: 31300418
[TBL] [Abstract][Full Text] [Related]
43. Is narrow-band imaging useful for histological evaluation of gastric mucosa-associated lymphoid tissue lymphoma after treatment?
Nonaka K; Ohata K; Matsuhashi N; Shimizu M; Arai S; Hiejima Y; Kita H
Dig Endosc; 2014 May; 26(3):358-64. PubMed ID: 24118642
[TBL] [Abstract][Full Text] [Related]
44. [Clinical and morphological aspects of MALT-gastric lymphoma].
Malikhova OA; Poddubnyĭ BK; Poddubnaia IV; Moskalenko OA; Kokosadze NV; Probatova NA; Kovrigina AM
Eksp Klin Gastroenterol; 2010; (6):24-9. PubMed ID: 20731161
[TBL] [Abstract][Full Text] [Related]
45. Sustained response to lenalidomide for early relapsed marginal zone lymphoma.
Ibrahimi S; Vidal G; Mukherjee S; Alhyari L; Scordino T; Cherry M
Blood Cells Mol Dis; 2018 Jul; 71():53-54. PubMed ID: 29496374
[No Abstract] [Full Text] [Related]
46. Cereblon (
Iskierka-Jażdżewska E; Canzian F; Stępień A; Martino A; Campa D; Stein A; Krawczyk-Kuliś M; Rybicka-Ramos M; Kyrcz-Krzemień S; Butrym A; Mazur G; Jurczyszyn A; Zawirska D; Grząśko N; Tomczak W; Subocz E; Wątek M; Pasiarski M; Rymko M; Całbecka M; Druzd-Sitek A; Walewski J; Kruszewski M; Raźny M; Zaucha JM; Dudziński M; Gaj P; Robak T; Warzocha K; Jamroziak K
Leuk Lymphoma; 2020 Mar; 61(3):699-706. PubMed ID: 31746254
[TBL] [Abstract][Full Text] [Related]
47. Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
Kiesewetter B; Mayerhoefer ME; Lukas J; Zielinski CC; Müllauer L; Raderer M
Ann Hematol; 2014 Feb; 93(2):249-53. PubMed ID: 23925930
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
[TBL] [Abstract][Full Text] [Related]
49. The preclinical activity of lenalidomide in indolent urothelial carcinoma.
Jian W; Levitt JM; Lerner SP; Sonpavde G
Anticancer Res; 2014 Jul; 34(7):3383-9. PubMed ID: 24982344
[TBL] [Abstract][Full Text] [Related]
50. [Clinical features and prognosis of mucosa-associated lymphoid tissue lymphoma].
Tian L; Zhang C; Liu W; Wang X; Zheng W; Xie Y; Lin N; Ying Z; Ping L; Deng L; Song Y; Zhu J
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):759-62. PubMed ID: 24844960
[TBL] [Abstract][Full Text] [Related]
51. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.
Deutsch AJ; Aigelsreiter A; Steinbauer E; Frühwirth M; Kerl H; Beham-Schmid C; Schaider H; Neumeister P
J Pathol; 2008 Aug; 215(4):431-44. PubMed ID: 18561120
[TBL] [Abstract][Full Text] [Related]
52. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.
Grünberger B; Wöhrer S; Streubel B; Formanek M; Petkov V; Puespoek A; Haefner M; Hejna M; Jaeger U; Chott A; Raderer M
J Clin Oncol; 2006 Mar; 24(9):1370-5. PubMed ID: 16549831
[TBL] [Abstract][Full Text] [Related]
53. First Line Systemic Treatment for MALT Lymphoma-Do We Still Need Chemotherapy? Real World Data from the Medical University Vienna.
Kiesewetter B; Simonitsch-Klupp I; Mayerhoefer ME; Dolak W; Lukas J; Raderer M
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33256131
[TBL] [Abstract][Full Text] [Related]
54. Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS.
Qian X; Dimopoulos MA; Amatangelo M; Bjorklund C; Towfic F; Flynt E; Weisel KC; Ocio EM; Yu X; Peluso T; Sternas L; Zaki M; Moreau P; Thakurta A
Leuk Lymphoma; 2019 Feb; 60(2):462-470. PubMed ID: 30068263
[TBL] [Abstract][Full Text] [Related]
55. Lenalidomide in lymphomas and chronic lymphocytic leukemia.
Wiernik PH
Expert Opin Pharmacother; 2013 Mar; 14(4):475-88. PubMed ID: 23356486
[TBL] [Abstract][Full Text] [Related]
56. [Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type (MALT lymphoma)].
Takahashi T; Suzumiya J
Nihon Rinsho; 2014 Mar; 72(3):493-8. PubMed ID: 24724410
[TBL] [Abstract][Full Text] [Related]
57. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
Jäger G; Neumeister P; Brezinschek R; Hinterleitner T; Fiebiger W; Penz M; Neumann HJ; Mlineritsch B; DeSantis M; Quehenberger F; Chott A; Beham-Schmid C; Höfler G; Linkesch W; Raderer M
J Clin Oncol; 2002 Sep; 20(18):3872-7. PubMed ID: 12228207
[TBL] [Abstract][Full Text] [Related]
58. Antisecretory medication is associated with decreased Helicobacter pylori detection in gastric marginal zone lymphoma.
Schaberg KB; Evans MF; Wilcox R; Lewis MR
Ann Diagn Pathol; 2015 Dec; 19(6):397-402. PubMed ID: 26615705
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma.
Bila J; Sretenovic A; Jelicic J; Tosic N; Glumac I; Fekete MD; Antic D; Balint MT; Markovic O; Milojevic Z; Radojkovic M; Trajkovic G; Puric M; Pavlovic S; Mihaljevic B
Clin Lymphoma Myeloma Leuk; 2016 Nov; 16(11):610-615. PubMed ID: 27618360
[TBL] [Abstract][Full Text] [Related]
60. Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.
Nowakowski GS; LaPlant B; Macon WR; Reeder CB; Foran JM; Nelson GD; Thompson CA; Rivera CE; Inwards DJ; Micallef IN; Johnston PB; Porrata LF; Ansell SM; Gascoyne RD; Habermann TM; Witzig TE
J Clin Oncol; 2015 Jan; 33(3):251-7. PubMed ID: 25135992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
